Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SINOPEG is a China-based drug delivery and medical materials company focused on research, development, manufacturing, and sales of PEG derivatives, PEGylation reagents, PEGylated lipids, lipid nanoparticle excipients, block copolymers, hydrogels, and related pharmaceutical materials. The company positions itself as a supplier and development partner for long-acting protein and peptide drugs, mRNA vaccines, small nucleic acid therapeutics, gene therapies, liposomal drugs, ADCs, PROTACs, and medical devices. In addition to catalog products, it offers custom synthesis, CDMO support, and formulation-related solutions for pharmaceutical and biotech customers. Its business appears to be primarily tools, excipients, and delivery-enabling materials rather than a traditional proprietary therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SINOPEG.